ProKidney to Participate in Fireside Chat at the Jefferies Healthcare Conference

WINSTON-SALEM, N.C., June 01, 2023 -- ProKidney Corp. , a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease , today announced that Dr. Tim Bertram, Chief... | June 1, 2023

Related Keywords

New York ,United States ,Ukraine ,Americans ,Selina Husain ,Glenn Schulman ,Dburns Mcclellan ,Tim Bertram ,Robert Flamm ,Lee Roth ,Prokidney Corp ,Exchange Commission ,Company Class ,Nasdaq ,Globenewswire Inc ,Chief Executive Officer ,Healthcare Conference ,Renal Autologous Cell Therapy ,Regenerative Medicine Advanced Therapy ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Prokidney Corp Stock Exchange ,News ,Information ,Press Release ,Pune ,023 ,Prokidney ,Reading ,Gate ,Ellular ,Herapeutics ,Company ,Ocused ,N ,Hronic ,Kidney ,Disease ,Oday ,Nnounced ,Hat ,Im Prok Kyg7s53r1049 ,